VTE 28 day treatment period [clinicaltrials_resource:50da317d46fb2f819b7c7210eaea42f4]
Incidence of VTE during the 28-day treatment period, including death due to VTE
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
VTE 28 day treatment period [clinicaltrials_resource:50da317d46fb2f819b7c7210eaea42f4]
Incidence of VTE during the 28-day treatment period, including death due to VTE
Bio2RDF identifier
50da317d46fb2f819b7c7210eaea42f4
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:50da317d46fb2f819b7c7210eaea42f4
measure [clinicaltrials_vocabulary:measure]
time frame [clinicaltrials_vocabulary:time-frame]
28 day treatment period
description
Incidence of VTE during the 28-day treatment period, including death due to VTE
identifier
clinicaltrials_resource:50da317d46fb2f819b7c7210eaea42f4
title
VTE 28 day treatment period
@en
type
label
VTE 28 day treatment period [clinicaltrials_resource:50da317d46fb2f819b7c7210eaea42f4]
@en